Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in the CLEOPATRA study.
Michael Ewer
Consultant or Advisory Role - AstraZeneca (U); Boehringer Ingelheim (U); Genentech (U)
José Baselga
Consultant or Advisory Role - Roche/Genentech
Emma Clark
Employment or Leadership Position - Roche
Stock Ownership - AstraZeneca
Mark Benyunes
Employment or Leadership Position - Genentech
Graham Ross
Employment or Leadership Position - Roche
Stock Ownership - Roche
Sandra M. Swain
Consultant or Advisory Role - Nektar (U); Novartis (U); Roche/Genentech (U); Sanofi (U)
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer; Roche/Genentech; Sanofi
Other Remuneration - Sanofi